The Kano State Drugs and Medical Consumables Supply Agency (DMCSA) has achieved a major financial milestone, successfully paying off ₦980 million out of the ₦1.17 billion debt inherited from the previous administration.
The agency described the feat as a demonstration of its commitment to fiscal responsibility, operational transparency, and the revitalization of healthcare service delivery in the state.
Drug Supply in Kano Public Facilities Rises from 30 to 90%-DMCSA
Speaking during the 8th Quarterly Review Meeting held at the agency’s conference hall, the Director-General of DMCSA, Pharm. Gali Sule, said the debt repayment was achieved through the effective implementation of transparency and accountability mechanisms, alongside strategic financial reforms.
Pharm. Sule reaffirmed the agency’s commitment to clearing the remaining balance and further strengthening partnerships with key stakeholders in the public health sector.
The Director-General also highlighted notable achievements recorded under his leadership, including a dramatic improvement in drug availability at public health facilities rising from 30% to 97% and a 40% reduction in the cost of government-supplied drugs and consumables compared to open-market prices.
Kano DMCSA Opens Bids for 2026 Drug, Medical Supply Contracts
He revealed that the agency’s financial status improved significantly, with its fund value increasing from a negative ₦102 million in July 2023 to ₦377 million as of September 2025.
Declaring the meeting open, the Commissioner for Health, Dr. Abubakar Labaran Yusuf, congratulated the DMCSA leadership for its remarkable performance and financial turnaround.
He also commended development partners for their continued support to Kano’s health sector and assured them that all donated tools and equipment would be properly utilized to strengthen service delivery.